These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9420052)

  • 1. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
    Sergerie Y; Boivin G
    J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
    Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
    Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.
    Lin JC; De Clercq E; Pagano JS
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
    Maggs DJ; Clarke HE
    Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    Medveczky MM; Horvath E; Lund T; Medveczky PG
    AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
    Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
    Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
    Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
    Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
    J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
    Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
    Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.